A compound and an organic optoelectronic device are provided. The compound has the following chemical formula (I):

##STR00001##

chemical formula (I). In the chemical formula (I), X.sub.1 to X.sub.2 are independently selected from O, S,

##STR00002##

and substituted or unsubstituted methylene, and a substituent is selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. X.sub.3 is selected from O, S, substituted or unsubstituted methylene, substituted or unsubstituted methylene, and substituted or unsubstituted silylene, and a substituent is selected hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. R.sub.1 to R.sub.17 are independently selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl.

A compound and an organic optoelectronic device are provided. The compound has the following chemical formula (I):

##STR00001##

chemical formula (I). In the chemical formula (I), X.sub.1 to X.sub.2 are independently selected from O, S,

##STR00002##

and substituted or unsubstituted methylene, and a substituent is selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. X.sub.3 is selected from O, S, substituted or unsubstituted methylene, substituted or unsubstituted methylene, and substituted or unsubstituted silylene, and a substituent is selected hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl. R.sub.1 to R.sub.17 are independently selected from hydrogen, deuterium, C.sub.1 to C.sub.30 alkyl, C.sub.1 to C.sub.30 heteroatom-substituted alkyl, C.sub.6 to C.sub.30 aryl, and C.sub.2 to C.sub.30 heteroaryl.

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Provided herein is a compound of Formula (I-I), or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I-I), and methods of using the compounds, e.g. in the treatment of CNS-related disorders. ##STR00001##

The present invention relates to a new process for manufacturing (6aR,10aR)-7-propyl-6,6 a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-g]quinoline with formula (Ib) below, (4aR,10aR)-1-Propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol with formula (I) below and salts thereof.

##STR00001##

Both compounds are for use in the treatment of neurodegenerative diseases and disorders such as Parkinson's Disease. The invention also relates to new intermediate compounds of said process.

The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.